Thursday, October 29, 2026

Google Alert - lose weight

Google
lose weight
As-it-happens update ⋅ October 29, 2026
NEWS
A new late-stage study suggests Eli Lilly's experimental weekly injection retatrutide may help adults with Type 2 diabetes lose more weight than ...
Facebook Twitter Flag as irrelevant
See more results | Edit this alert
You have received this email because you have subscribed to Google Alerts.
RSS Receive this alert as RSS feed
Send Feedback

Google Alert - lose weight

Google
lose weight
As-it-happens update ⋅ October 28, 2026
NEWS
Intermittent fasting combined with exercise reduces body fat, but new research questions whether those benefits translate into better cycling ...
Facebook Twitter Flag as irrelevant
Bariatric surgery can produce substantial weight loss, but some patients later regain weight, potentially reducing the procedure's long-term health ...
Facebook Twitter Flag as irrelevant
... losing weight. But is the proteinmaxxing diet and lifestyle sustainable? Do the results after one week make the trend worth continuing? For the ...
Facebook Twitter Flag as irrelevant
Compare Wegovy GLP-1 weight-loss pills and injections, their effectiveness, side effects and dosing, and why doctors warn against buying the pills ...
Facebook Twitter Flag as irrelevant
Eli Lilly said on Wednesday its experimental next-generation obesity drug, retatrutide, outperformed Novo Nordisk's Ozempic on blood sugar control ...
Facebook Twitter Flag as irrelevant
Trying to lose weight after 40 without results? Dr. Corey Aplin joins Great Day to explain metabolic friction — like driving with the brakes on.
Facebook Twitter Flag as irrelevant
... weight management. Patients in the Western Isles are being prescribed drugs used for weight loss and diabetes at almost three times the rate of any ...
Facebook Twitter Flag as irrelevant
In previous studies, the drug has already shown a bariatric-surgery level of weight loss in patients with obesity, likely positioning it to be the ...
Facebook Twitter Flag as irrelevant
See more results | Edit this alert
You have received this email because you have subscribed to Google Alerts.
RSS Receive this alert as RSS feed
Send Feedback

Wednesday, October 28, 2026

Google Alert - lose weight

Google
lose weight
As-it-happens update ⋅ October 28, 2026
NEWS
In the first head-to-head trial of Ozempic versus Eli Lilly's new "King Kong" drug retatrutide, the next-generation drug led to more weight loss.
Facebook Twitter Flag as irrelevant
CagriSema is a weight-loss medication that combines two powerful hormones, cagrilintide and semaglutide. Novo Nordisk is seeking FDA approval.
Facebook Twitter Flag as irrelevant
A new poll finds 3 in 4 workers received no ongoing support to maintain weight loss through their benefits.
Facebook Twitter Flag as irrelevant
Eli Lilly's next-gen weight loss drug retatrutide soundly beat Novo's approved medicine Ozempic in weight loss and blood sugar reduction, ...
Facebook Twitter Flag as irrelevant
Initially transforming her diet and losing two stone, Deby started on the GLP-1 weight loss injection Mounjaro in September 2025, losing a further 4st ...
Facebook Twitter Flag as irrelevant
Lilly's investigational drug retatrutide was more effective at lowering blood sugar and cutting weight than Ozempic in a large diabetes study.
Facebook Twitter Flag as irrelevant
New weight-loss drugs from Novo Nordisk, Eli Lilly, Pfizer, Roche, Amgen and Viking Therapeutics offer a look at where obesity treatment could go ...
Facebook Twitter Flag as irrelevant
... lose weight,” he says, which could create additional risks. As of late 2026, the federal litigation against Novo Nordisk and Eli Lilly is ...
Facebook Twitter Flag as irrelevant
... losing weight. But is the proteinmaxxing diet and lifestyle sustainable? Do the results after one week make the trend worth continuing? Subscribe ...
Facebook Twitter Flag as irrelevant
See more results | Edit this alert
You have received this email because you have subscribed to Google Alerts.
RSS Receive this alert as RSS feed
Send Feedback

Google Alert - lose weight

Google
lose weight
As-it-happens update ⋅ October 28, 2026
NEWS
Eli Lilly's experimental GLP-1 weight loss drug retatrutide significantly reduced obstructive sleep apnea symptoms and improved the apnea-hypopnea ...
Facebook Twitter Flag as irrelevant
... lose weight during the challenging holiday season. “It helped keep me ... lost 6% body fat between the two assessments. “It was encouraging ...
Facebook Twitter Flag as irrelevant
Eli Lilly's experimental next-generation drug retatrutide outperformed a lower-dose version of Novo Nordisk's Ozempic on blood sugar control ​and ...
Facebook Twitter Flag as irrelevant
Michella Giunta (@michelle.giunta) told Instagram about her ovarian cyst, which weighed 18lbs. She alleged that doctors told her to exercise and ...
Facebook Twitter Flag as irrelevant
This Country star Daisy May Cooper's incredible weight-loss transformation: Actress shed 10st by following brutal keto diet, ditching booze and ...
Facebook Twitter Flag as irrelevant
PRNewswire/ -- Eli Lilly and Company (NYSE: LLY), the maker of Mounjaro (tirzepatide) and Foundayo (orforglipron), today announced positive ...
Facebook Twitter Flag as irrelevant
The rise of GLP-1 medication use over the past decade has transformed societal perceptions of weight loss and created different stigmas ...
Facebook Twitter Flag as irrelevant
See more results | Edit this alert
You have received this email because you have subscribed to Google Alerts.
RSS Receive this alert as RSS feed
Send Feedback
Related Posts Plugin for WordPress, Blogger...